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OBJECTIVE: To estimate prevalence of Urinary Inconti-
nence (UI) in the Portuguese population. To determine the
costs of treatment (including incontinent pad usage) with
Tolterodine for patients suffering from chronic UI.
METHODS: Data from the National Health Survey per-
formed in 1995–96, involving a representative sample of
49718 people across mainland Portugal, was analyzed to
determine age, sex-specific and age-standardized preva-
lence rates of UI. The average consumption of pads by in-
continent patients was estimated from the information pro-
vided by the Centro Regional de Saúde from Madeira
Island, a region where pads are reimbursed.
RESULTS: The global prevalence of urinary incontinence
in Portugal was of 4,3%, being 2,6% in males and 5,8% in
females. Age and sex adjusted prevalence rates were of
1,9% in males while 4,4% in females. Age and sex specific
prevalence rates increase with age from 15 years onwards
in both sexes, being higher in females across all age groups.
Above 65 years of age 10% of men and 12% of women
suffer from urinary incontinence. Of these, 68,8% are
likely to suffer from chronic urinary incontinence. This is
the estimated burden of the disease in the general Portu-
guese population. Urinary incontinent chronic patients use
on average 4 pads per 24 hours, normally using 3 pads dur-
ing the day and 1 pad at night. Comparing the average pad
costs per day with using Tolterodine, the difference is re-
markable (648$00 PTE versus 334$60 PTE). The eco-
nomic impact of such use would reduce the health expendi-
ture in UI patients significantly.
CONCLUSION: The prevalence of UI in Portugal is
within the limits of what is mentioned in other community-
based studies. The average daily costs of treatment with
Tolterodine are lower when compared with pad usage.
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OBJECTIVES: To apply bootstrap techniques to derive
confidence intervals (CIs) for cost differences between two
anaesthetic regimes, and to compare with standard para-
metric methods for deriving CIs.
METHODS: In a cardiac surgery clinical trial, patients were
randomized to one of two anaesthetic regimes, either propo-
fol or midazolam, for the induction and maintenance of an-
esthesia, and sedation post-surgery in ICU. A cost compari-
son of these two regimes was published in 1996, with all
drug usage and ICU nursing time costs. Parametric methods
were used to construct 95% CIs for the difference between
propofol and midazolam. Untransformed parametric analy-
sis of cost data often fails because of distributional skew-
ness. Therefore, log-transformed analysis was undertaken to
overcome the skewness problem. More recently, log-trans-
formation has become a discredited strategy because health-
care decision-makers focus on total budgets—for instance,
the total annual budget available to provide surgery at a
particular centre. The only estimator directly linked to this
total cost is the arithmetic mean—therefore any analysis
based upon geometric means, arising from log-transforma-
tion, is inappropriate. Other authors have therefore recom-
mended bootstrap techniques to produce CIs for cost differ-
ences on an untransformed scale. This approach is not
invalidated by distributional skewness.
RESULTS: With 37 propofol and 33 midazolam patients,
a comparison of drug plus nursing costs showed an advan-
tage per subject for propofol of £43.23 (95% CI: £3.21
to £89.67). An untransformed two-sample t-test proved in-
appropriate, because the necessary distributional assump-
tions were not satisfied. Bootstrap CIs for the cost differ-
ence were then constructed using four different bootstrap
techniques. All bootstrap CIs showed a striking similarity
to the untransformed estimates above, demonstrating the
robustness of the t-test and conventional parametric meth-
ods, despite distributional skewness.
CONCLUSIONS: Both untransformed and bootstrap esti-
mates should be presented—hopefully, the two methods will
be in agreement and provide mutually supportive evidence.
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OBJECTIVE: To develop and validate a brief survey of mi-
graine-related quality of life issues. Unlike other instru-
ments that define the impact of acute treatment, the Qual-
ity of Life with Migraine (QOLWM) questionnaire was
designed to assess the chronic impact of migraine.
METHODS: Major issues related to living with chronic,
frequent migraine headaches were condensed into seven
topics. Each item was structured as a question about fre-
quency and a question about bothersomeness. Item scores
were the products of frequency and bothersomeness. The
total score was the sum of the seven item scores. People
with migraine who voluntarily responded to a headache
survey also completed the QOLWM and the Headache
Disability Index (HDI).
RESULTS: The QOLWM was completed in full by 994
adults (81% women) with mean total score 77.98  40.49
(range 7–175). There were no floor or ceiling effects. Inter-
nal consistency reliability (Cronbach’s alpha) of 0.93 was
excellent, with item-scale correlations of 0.59–0.83. The
eigenvalue of the single factor was 4.78, with item loadings
